Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC
about
Caveolin-1, a stress-related oncotarget, in drug resistanceCAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype.∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299.Network Pharmacology-Based Validation of Caveolin-1 as a Key Mediator of Ai Du Qing Inhibition of Drug Resistance in Breast Cancer
P2860
Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Aberrant promoter methylation ...... chemotherapy in advanced NSCLC
@ast
Aberrant promoter methylation ...... chemotherapy in advanced NSCLC
@en
Aberrant promoter methylation ...... chemotherapy in advanced NSCLC
@nl
type
label
Aberrant promoter methylation ...... chemotherapy in advanced NSCLC
@ast
Aberrant promoter methylation ...... chemotherapy in advanced NSCLC
@en
Aberrant promoter methylation ...... chemotherapy in advanced NSCLC
@nl
prefLabel
Aberrant promoter methylation ...... chemotherapy in advanced NSCLC
@ast
Aberrant promoter methylation ...... chemotherapy in advanced NSCLC
@en
Aberrant promoter methylation ...... chemotherapy in advanced NSCLC
@nl
P2093
P2860
P1433
P1476
Aberrant promoter methylation ...... chemotherapy in advanced NSCLC
@en
P2093
Adam Marcus
Courtney Lombardo
Fadlo R Khuri
Johann C Brandes
Khanjan Gandhi
Paula M Vertino
Seth A Brodie
Shaojin You
P2860
P304
P356
10.1371/JOURNAL.PONE.0107124
P407
P577
2014-09-15T00:00:00Z